TO Compare the Triple Drug Therapy and Dual Therapy .
NCT02075242 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 170
Last updated 2014-03-03
Summary
Study to Compare the Safety and Efficacy of Tacrolimus and Steroids in Combination With Mycophenolate Mofetil or Without Mycophenolate Mofetil in Liver Transplantation with Hepatitis B Virus(HBsAg) Positive
Conditions
- HEPATITIS
Interventions
- DRUG
-
Mycophenolate Mofetil
experimental group receive Tacrolimus as a main immunosuppressants and assistant is My-rept capsule®(Mycophenolate Mofetil),
- DRUG
-
control group receive same immunosuppressants except for My-rept capsule®(Mycophenolate Mofetil- investigational product
Sponsors & Collaborators
-
Asan Medical Center
lead OTHER
Principal Investigators
-
Sung-Gyu Lee · Asan Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2016-01-31
- Completion
- 2016-01-31
Countries
- South Korea
Study Locations
More Related Trials
-
HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102
NCT03519113 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Randomized, Double-Blind Trial of Antroquinonol in Patients With Chronic Hepatitis B
NCT03625102 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in Healthy Volunteers and in Participants With Chronic Hepatitis B to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7020531
NCT02956850 ·Status: COMPLETED ·Phase: PHASE1
-
Antiviral Efficacy of the Combination Treatment With Poly IC and Entecavir for Chronic Hepatitis B
NCT02532413 ·Status: UNKNOWN ·Phase: PHASE4
-
Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation
NCT02125071 ·Status: COMPLETED
-
Safety and Tolerability of TG1050: A Dose-finding Study
NCT02428400 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-Infection
NCT05467553 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of Addition of Fecal Microbiota Transplant (FMT) and Plasma Exchange to Tenofovir in Comparison to Monotherapy With Tenofovir in ACLF-HBV
NCT04431375 ·Status: UNKNOWN ·Phase: NA
-
A Study of TQ-A3334 Combined With Entecavir in the Treatment of Chronic Hepatitis B
NCT04180150 ·Status: UNKNOWN ·Phase: PHASE2
-
Stratified vs Routine Prophylaxis in Living Kidney Transplantation From HBsAg+ Donors to HBsAg- Recipients
NCT04562051 ·Status: RECRUITING
-
Plasma Purification and Chronic Hepatitis B
NCT04518553 ·Status: UNKNOWN ·Phase: NA
-
Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir.
NCT03241641 ·Status: COMPLETED ·Phase: PHASE4
-
A Non-invasive Model to Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B
NCT06041022 ·Status: UNKNOWN
-
Non-Invasive Model for Fibrosis Regression in HBV Patients
NCT06874127 ·Status: RECRUITING
-
Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis
NCT01943617 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis B
NCT06566248 ·Status: RECRUITING ·Phase: PHASE2
-
Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B
NCT02496897 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
NCT04896255 ·Status: RECRUITING
-
Safely Discontinue Antiviral Treatment in Patients With Chronic Hepatitis B
NCT04782375 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus Infection
NCT07245953 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Randomized Controlled Trial Comparing the Efficacy and Safety of FMT in Hepatitis B Reactivation Leads to Acute on Chronic Liver Failure.
NCT02689245 ·Status: COMPLETED ·Phase: NA
-
Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis B
NCT02482272 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection
NCT06644417 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine
NCT04289987 ·Status: COMPLETED ·Phase: PHASE2
-
A Real-World Study of Pegylated Interferon In Nucleoside-treated Patients With Chronic Hepatitis B
NCT03357822 ·Status: UNKNOWN ·Phase: PHASE4